Candriam SCA’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,866
| Closed | -$532K | – | 760 |
|
|
2023
Q1 | $532K | Sell |
2,866
-2,287
| -44% | -$425K | ﹤0.01% | 765 |
|
|
2022
Q4 | $1.12M | Sell |
5,153
-46,301
| -90% | -$10.1M | 0.01% | 679 |
|
|
2022
Q3 | $10.1M | Sell |
51,454
-2,353
| -4% | -$463K | 0.07% | 269 |
|
|
2022
Q2 | $11.5M | Sell |
53,807
-13,723
| -20% | -$2.94M | 0.09% | 206 |
|
|
2022
Q1 | $19.2M | Sell |
67,530
-62,879
| -48% | -$17.9M | 0.13% | 171 |
|
|
2021
Q4 | $49.1M | Sell |
130,409
-90,296
| -41% | -$34M | 0.31% | 77 |
|
|
2021
Q3 | $91.1M | Sell |
220,705
-17,442
| -7% | -$7.2M | 0.62% | 35 |
|
|
2021
Q2 | $88.1M | Buy |
238,147
+167,967
| +239% | +$62.1M | 0.6% | 38 |
|
|
2021
Q1 | $16.8M | Buy |
70,180
+11
| +0% | +$2.64K | 0.14% | 161 |
|
|
2020
Q4 | $17.5M | Buy |
70,169
+26,323
| +60% | +$6.58M | 0.14% | 162 |
|
|
2020
Q3 | $9.93M | Buy |
+43,846
| New | +$9.93M | 0.09% | 236 |
|